The treatment with fremanezumab becomes the first approved therapy to demonstrate efficacy in children and adolescents, a key stage of life as it is one of the most disabling and concentrates the peak...
Read more
Having alternatives with fewer drugs may reduce cumulative lifetime exposure to medication and offers new options in cases of resistance or intolerance to integrase inhibitors
Read more
El trabajo, coliderado por el IIBB-CSIC, ha descubierto que el fármaco “cabozantinib” activa una vía de alarma que delata al tumor y facilita su ataque por parte del sistema inmune
Read more
Compared with other antiretroviral treatments, dolutegravir leads to a more balanced microbiome, similar to that of people without HIV, with lower inflammation and reduced immune system activation
Read more
Published today in The Lancet, these positive results could lead to the regulatory approval of pimicotinib as an effective and well-tolerated therapeutic option, representing an important step forward...
Read more
The biotech company GAT Therapeutics is making progress in the development of GTX-11, a new oral drug candidate for the treatment of idiopathic pulmonary fibrosis. Preclinical results show that GTX-11...
Read more
La incubadora de alta tecnología alcanza el 85 % de ocupación en sus primeros siete meses de vida y se posiciona como un referente en la retención de talento científico.
Read more
Pharmacelera and Chemspace have announced the launch of a powerful new joint solution that integrates Chemspace Freedom Space 5.0 with Pharmacelera’s flagship virtual screening platform, exaScreen®...
Read more
A team from the Spanish National Cancer Research Centre has discovered a novel way in which tumor cells alter the brain to establish themselves and spread cancer.
Read more
A phase II clinical trial evaluated the efficacy and safety of GH001, an inhaled synthetic formulation of mebufotenin (5-MeO-DMT), a fast-acting psychedelic compound, in these patients.
Read more
Un estudio liderado por IBIMA y la Universidad de Camerino identifica fármacos de acción dual capaces de restaurar el control del apetito y reducir la ingesta compulsiva en episodios de estrés.
Read more
Este estudio del CBM-CSIC-UAM identifica un mecanismo desconocido hasta ahora que controla la producción de moléculas inflamatorias relevantes para esta enfermedad
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
